Altered immune response to exercise in patients with chronic fatigue syndrome/myalgic encephalomyelitis: a systematic literature review - PubMed (original) (raw)
- PMID: 24974723
Free article
Review
Altered immune response to exercise in patients with chronic fatigue syndrome/myalgic encephalomyelitis: a systematic literature review
Jo Nijs et al. Exerc Immunol Rev. 2014.
Free article
Abstract
An increasing number of studies have examined how the immune system of patients with Chronic Fatigue Syndrome (CFS), or myalgic encephalomyelitis, responds to exercise. The objective of the present study was to systematically review the scientific literature addressing exercise-induced immunological changes in CFS patients compared to healthy control subjects. A systematic literature search was conducted in the PubMed and Web of science databases using different keyword combinations. We included 23 case control studies that examined whether CFS patients, compared to healthy sedentary controls, have a different immune response to exercise. The included articles were evaluated on their methodological quality. Compared to the normal response of the immune system to exercise as seen in healthy subjects, patients with CFS have a more pronounced response in the complement system (i.e. C4a split product levels), oxidative stress system (i.e. enhanced oxidative stress combined with a delayed and reduced anti-oxidant response), and an alteration in the immune cells' gene expression profile (increases in post-exercise interleukin-10 and toll-like receptor 4 gene expression), but not in circulating pro- or anti-inflammatory cytokines. Many of these immune changes relate to post-exertional malaise in CFS, a major characteristic of the illness. The literature review provides level B evidence for an altered immune response to exercise in patients with CFS.
Similar articles
- Unravelling the nature of postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: the role of elastase, complement C4a and interleukin-1beta.
Nijs J, Van Oosterwijck J, Meeus M, Lambrecht L, Metzger K, Frémont M, Paul L. Nijs J, et al. J Intern Med. 2010 Apr;267(4):418-35. doi: 10.1111/j.1365-2796.2009.02178.x. J Intern Med. 2010. PMID: 20433584 - Exercise-induce hyperalgesia, complement system and elastase activation in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - a secondary analysis of experimental comparative studies.
Polli A, Van Oosterwijck J, Meeus M, Lambrecht L, Nijs J, Ickmans K. Polli A, et al. Scand J Pain. 2019 Jan 28;19(1):183-192. doi: 10.1515/sjpain-2018-0075. Scand J Pain. 2019. PMID: 30325737 - Differences in metabolite-detecting, adrenergic, and immune gene expression after moderate exercise in patients with chronic fatigue syndrome, patients with multiple sclerosis, and healthy controls.
White AT, Light AR, Hughen RW, Vanhaitsma TA, Light KC. White AT, et al. Psychosom Med. 2012 Jan;74(1):46-54. doi: 10.1097/PSY.0b013e31824152ed. Epub 2011 Dec 30. Psychosom Med. 2012. PMID: 22210239 Free PMC article. - Chronic fatigue syndrome and circulating cytokines: A systematic review.
Blundell S, Ray KK, Buckland M, White PD. Blundell S, et al. Brain Behav Immun. 2015 Nov;50:186-195. doi: 10.1016/j.bbi.2015.07.004. Epub 2015 Jul 3. Brain Behav Immun. 2015. PMID: 26148446 Review. - Inflammatory and oxidative and nitrosative stress cascades as new drug targets in myalgic encephalomyelitis and chronic fatigue syndrome.
Maes M. Maes M. Mod Trends Pharmacopsychiatry. 2013;28:162-74. doi: 10.1159/000343982. Epub 2013 Feb 27. Mod Trends Pharmacopsychiatry. 2013. PMID: 25224898 Review.
Cited by
- Prospective Biomarkers from Plasma Metabolomics of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Implicate Redox Imbalance in Disease Symptomatology.
Germain A, Ruppert D, Levine SM, Hanson MR. Germain A, et al. Metabolites. 2018 Dec 6;8(4):90. doi: 10.3390/metabo8040090. Metabolites. 2018. PMID: 30563204 Free PMC article. - Placenta Peptide Can Protect Mitochondrial Dysfunction through Inhibiting ROS and TNF-α Generation, by Maintaining Mitochondrial Dynamic Network and by Increasing IL-6 Level during Chronic Fatigue.
Muluye RA, Bian Y, Wang L, Alemu PN, Cui H, Peng X, Li S. Muluye RA, et al. Front Pharmacol. 2016 Sep 27;7:328. doi: 10.3389/fphar.2016.00328. eCollection 2016. Front Pharmacol. 2016. PMID: 27729861 Free PMC article. - Focus on post-exertional malaise when approaching ME/CFS in specialist healthcare improves satisfaction and reduces deterioration.
Wormgoor MEA, Rodenburg SC. Wormgoor MEA, et al. Front Neurol. 2023 Dec 1;14:1247698. doi: 10.3389/fneur.2023.1247698. eCollection 2023. Front Neurol. 2023. PMID: 38107643 Free PMC article. - Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome.
Komaroff AL, Lipkin WI. Komaroff AL, et al. Trends Mol Med. 2021 Sep;27(9):895-906. doi: 10.1016/j.molmed.2021.06.002. Epub 2021 Jun 7. Trends Mol Med. 2021. PMID: 34175230 Free PMC article. Review. - Interleukin-1 as a mediator of fatigue in disease: a narrative review.
Roerink ME, van der Schaaf ME, Dinarello CA, Knoop H, van der Meer JW. Roerink ME, et al. J Neuroinflammation. 2017 Jan 21;14(1):16. doi: 10.1186/s12974-017-0796-7. J Neuroinflammation. 2017. PMID: 28109186 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous